InvestorsHub Logo

VST7

03/20/17 12:09 PM

#37422 RE: LeGoose #37407

You missed a few parts of this filing,for instance the following; Below is a brief summary of the Increase:

The authorized Common Stock shall be increased to 7,000,000,000. This will not change the issued and issued shares of Common Stock, as of March 16, 2017.

AND;
EFFECTIVE DATE OF INCREASE

Pursuant to Rule 14c-2 under the Exchange Act, the Increase shall not be effective until a date at least twenty (20) days after the date on which this Information Statement has been mailed to the Stockholders. The Company anticipates that the actions contemplated hereby will be effected on or about the close of business on April 10, 2017.

Here's a part that IMO, needs to be looked at carefully;
Anti-Takeover Effects of the Increase

THE OVERALL EFFECT OF THE INCREASE MAY BE TO RENDER MORE DIFFICULT THE ACCOMPLISHMENT OF MERGERS OR THE ASSUMPTION OF CONTROL BY A PRINCIPAL STOCKHOLDER.

The Increase in our authorized shares could potentially be used by management to thwart a take-over attempt.

I cannot vouch for FBEC for anything regarding their reason for this increase? It may be to dilute? I don't know? BUT...

In comparison to similar OTC companies, I saw the OTC stock DEWM increase their A/S in Jan. 2014, from 2.5Bil to 4.5Bil, for the same reason, in order to thwart any hostile takeover attempts, peeps thought they were going to dilute & bailed but I stayed, a few weeks later DEWM ran from .0005 to .033 and DEWM NEVER did dilute, they got rid of their toxic debt & 3 years later, their O/S is still close to what is was then approx 2.4Bil.

I am not saying any of this in support of FBEC, all I am saying is that when you assume their reason for something is to dilute shareholder equity (it might be?) but if it's not, and your assumptions are wrong? You might miss out on a large run-up like DEWM had...